Omega Healthcare Investors, Inc.

Second-quarter 2026 revenue was $328 million, up from $283 million in Q2 2025. Net income available to common shareholders was $363 million, or $1.19 per share, versus $137 million, or $0.46 per share, a year ago, largely due to a $247 million gain on asset sales. Adjusted FFO was $261 million, or $0.83 per share, and FAD was $248 million, or $0.78 per share. Trailing 12-month operator EBITDAR coverage improved to 1.65x from 1.58x. Balance sheet metrics included $39 million of available cash, $145 million of restricted cash, $6 million of revolver borrowings on a $2 billion revolver, fixed charge coverage of 6.5x, and leverage of 3.3x. Full-year 2026 adjusted FFO guidance was increased to $3.22 to $3.26 per share from $3.19 to $3.25 per share, with the midpoint rising to $3.24. Management said guidance includes approximately $9 million of quarterly revenue impact from assets sold and loans repaid late in Q2, assumes $56 million of the $144 million in scheduled 2026 mortgage and other real estate loan maturities will convert to fee simple real estate, and assumes $180 million of non-real-estate-backed loans outstanding as of June 30 will be repaid during 2026, including about $148 million in Genesis loans. The company also included the $0.01 common dividend increase announced last week.

Taylor Pickett framed the call as a reflection on how the nursing and senior housing sectors have evolved over 25 years and argued Omega has adapted well by broadening beyond triple-net SNFs into senior housing, U.K. care homes and operating structures like SHOP and RIDEA. His tone was highly upbeat about Omega’s future, emphasizing culture, conservative balance sheet management and a growing set of products to solve partner capital needs. He said the company has the right people and capital allocation approach to generate outsized results over the next decade.

Bob Stephenson highlighted a strong balance sheet and disciplined capital allocation. He pointed to about $700 million of proceeds from asset sales and loan repayments used to reduce revolver borrowings to $6 million, along with $39 million of available cash and $145 million of restricted cash, and noted the next scheduled debt maturity is not until April 2027. He also emphasized the raised full-year AFFO guide of $3.22 to $3.26 per share and explained that the company is balancing asset sales, repayments and redeployment to support future growth.

Analysts focused on the new U.K. OpCo/RIDEA structure, SHOP growth, and whether Omega is seeing enough acquisition opportunities as competition intensifies. Management said the U.K. transition reflected alignment of interest with the operator and the chance to earn outsized returns, while saying the SHOP pipeline is active and increasingly focused on value-add deals. They also said there is no major operator watch list, Texas coverage is not a concern, and the dividend increase was a board decision based on improved portfolio coverage rather than the CommuniCare gain.